US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 44.850
  • +0.150+0.34%
Close Apr 26 16:00 ET
  • 44.900
  • +0.050+0.11%
Post 19:50 ET
90.92BMarket Cap-14467P/E (TTM)

Bristol-Myers Squibb Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
4.66%11.87B
-2.50%45.01B
0.62%11.48B
-2.25%10.97B
-5.56%11.23B
-2.67%11.34B
-0.49%46.16B
-4.83%11.41B
-3.49%11.22B
1.57%11.89B
Operating revenue
4.48%11.69B
-2.26%44.39B
0.60%11.32B
-1.85%10.78B
-5.03%11.1B
-2.64%11.19B
-0.78%45.41B
-4.93%11.25B
-3.94%10.99B
1.04%11.68B
Cost of revenue
14.26%2.93B
5.48%10.69B
5.86%2.75B
6.50%2.51B
5.74%2.88B
3.84%2.57B
1.98%10.14B
10.06%2.59B
2.71%2.35B
10.93%2.72B
Gross profit
1.85%8.93B
-4.74%34.31B
-0.92%8.73B
-4.57%8.46B
-8.91%8.35B
-4.42%8.77B
-1.16%36.02B
-8.47%8.81B
-5.01%8.87B
-0.91%9.17B
Operating expense
17.04%7.42B
-2.97%26.12B
-4.07%6.83B
-3.92%6.5B
-1.16%6.45B
-2.60%6.34B
-3.55%26.92B
-2.33%7.12B
-7.49%6.77B
-5.53%6.53B
Selling and administrative expenses
34.34%2.37B
-0.54%7.77B
-8.52%2.07B
3.78%2B
8.23%1.93B
-3.77%1.76B
1.61%7.81B
-3.74%2.27B
7.94%1.93B
-5.05%1.79B
-Selling and marketing expense
34.34%2.37B
----
----
3.78%2B
----
-3.77%1.76B
----
----
7.94%1.93B
----
Research and development costs
16.11%2.7B
-2.21%9.3B
-1.27%2.48B
-7.28%2.24B
-2.71%2.26B
2.70%2.32B
-6.73%9.51B
-0.32%2.51B
-18.86%2.42B
-6.34%2.32B
Depreciation amortization depletion
4.48%2.36B
-5.71%9.05B
-2.77%2.28B
-6.70%2.26B
-6.62%2.26B
-6.66%2.26B
-4.27%9.6B
-3.06%2.34B
-5.03%2.42B
-5.10%2.42B
-Depreciation and amortization
4.48%2.36B
-5.71%9.05B
-2.77%2.28B
-6.70%2.26B
-6.62%2.26B
-6.66%2.26B
-4.27%9.6B
-3.06%2.34B
-5.03%2.42B
-5.10%2.42B
Operating profit
-37.75%1.51B
-9.98%8.2B
12.34%1.9B
-6.67%1.96B
-28.05%1.9B
-8.88%2.43B
6.64%9.1B
-27.61%1.69B
3.96%2.1B
12.71%2.64B
Net non-operating interest income expense
-47.57%-425M
5.36%-1.17B
-7.48%-316M
6.35%-280M
9.90%-282M
11.66%-288M
7.65%-1.23B
8.98%-294M
8.84%-299M
5.15%-313M
Non-operating interest expense
47.57%425M
-5.36%1.17B
7.48%316M
-6.35%280M
-9.90%282M
-11.66%288M
-7.65%1.23B
-8.98%294M
-8.84%299M
-5.15%313M
Other net income (expense)
-2,113.58%-12.61B
987.42%1.41B
-81.05%87M
11.98%458M
164.69%240M
195.43%626M
-117.77%-159M
388.68%459M
-12.23%409M
19.52%-371M
Gain on sale of security
637.74%285M
145.87%289M
-19.84%198M
181.58%107M
113.17%37M
91.64%-53M
-180.36%-630M
--247M
--38M
-275.63%-281M
Special income (charges)
-11,557.76%-13.29B
63.99%-260M
-69.68%161M
-4.39%-214M
42.32%-323M
123.77%116M
30.44%-722M
24.36%531M
54.85%-205M
46.97%-560M
-Less：Restructuring and merger&acquisition
6,258.37%13.29B
14.46%1.51B
350.32%698M
70.81%275M
-39.34%330M
-54.66%209M
-2.15%1.32B
-24.76%155M
-63.33%161M
-46.82%544M
-Less:Other special charges
100.62%2M
-187.84%-390M
-97.95%3M
-238.64%-61M
-143.75%-7M
-236.55%-325M
22.31%444M
342.42%146M
238.46%44M
-63.64%16M
-Gain on sale of business
----
-17.35%862M
3.61%862M
--0
--0
----
54.52%1.04B
24.92%832M
--0
--0
Other non- operating income (expenses)
-28.77%401M
15.84%1.38B
14.73%-272M
-1.91%565M
11.91%526M
20.82%563M
3.83%1.19B
-104.49%-319M
26.59%576M
8.05%470M
Income before tax
-515.74%-11.52B
9.43%8.44B
-9.95%1.67B
-3.26%2.14B
-5.06%1.86B
64.20%2.77B
-4.75%7.71B
0.05%1.86B
2.41%2.21B
26.08%1.96B
Income tax
-22.07%392M
-70.76%400M
46.99%-88M
-66.22%203M
-141.21%-218M
24.50%503M
26.20%1.37B
67.70%-166M
-0.66%601M
7.52%529M
Net income
-625.28%-11.91B
26.71%8.04B
-12.99%1.76B
20.27%1.93B
45.35%2.08B
76.70%2.27B
-9.54%6.35B
-14.63%2.03B
3.61%1.61B
34.68%1.43B
Net income continuous Operations
-625.28%-11.91B
26.71%8.04B
-12.99%1.76B
20.27%1.93B
45.35%2.08B
76.70%2.27B
-9.54%6.35B
-14.63%2.03B
3.61%1.61B
34.68%1.43B
Minority interest income
-40.00%3M
-16.67%15M
0
200.00%6M
-50.00%4M
0.00%5M
-10.00%18M
3M
-66.67%2M
33.33%8M
Net income attributable to the parent company
-626.57%-11.91B
26.84%8.03B
-12.86%1.76B
20.05%1.93B
45.88%2.07B
77.00%2.26B
-9.54%6.33B
-14.76%2.02B
3.88%1.61B
34.69%1.42B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-626.57%-11.91B
26.84%8.03B
-12.86%1.76B
20.05%1.93B
45.88%2.07B
77.00%2.26B
-9.54%6.33B
-14.76%2.02B
3.88%1.61B
34.69%1.42B
Basic earnings per share
-645.37%-5.89
30.64%3.88
-9.38%0.87
25.33%0.94
47.76%0.99
80.00%1.08
-5.71%2.97
-12.86%0.96
7.14%0.75
42.55%0.67
Diluted earnings per share
-650.47%-5.89
30.85%3.86
-8.42%0.87
24.00%0.93
50.00%0.99
81.36%1.07
-5.45%2.95
-11.21%0.95
8.70%0.75
40.43%0.66
Dividend per share
5.26%0.6
5.48%2.31
5.26%0.6
5.56%0.57
5.56%0.57
5.56%0.57
8.96%2.19
5.56%0.57
10.20%0.54
10.20%0.54
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 4.66%11.87B-2.50%45.01B0.62%11.48B-2.25%10.97B-5.56%11.23B-2.67%11.34B-0.49%46.16B-4.83%11.41B-3.49%11.22B1.57%11.89B
Operating revenue 4.48%11.69B-2.26%44.39B0.60%11.32B-1.85%10.78B-5.03%11.1B-2.64%11.19B-0.78%45.41B-4.93%11.25B-3.94%10.99B1.04%11.68B
Cost of revenue 14.26%2.93B5.48%10.69B5.86%2.75B6.50%2.51B5.74%2.88B3.84%2.57B1.98%10.14B10.06%2.59B2.71%2.35B10.93%2.72B
Gross profit 1.85%8.93B-4.74%34.31B-0.92%8.73B-4.57%8.46B-8.91%8.35B-4.42%8.77B-1.16%36.02B-8.47%8.81B-5.01%8.87B-0.91%9.17B
Operating expense 17.04%7.42B-2.97%26.12B-4.07%6.83B-3.92%6.5B-1.16%6.45B-2.60%6.34B-3.55%26.92B-2.33%7.12B-7.49%6.77B-5.53%6.53B
Selling and administrative expenses 34.34%2.37B-0.54%7.77B-8.52%2.07B3.78%2B8.23%1.93B-3.77%1.76B1.61%7.81B-3.74%2.27B7.94%1.93B-5.05%1.79B
-Selling and marketing expense 34.34%2.37B--------3.78%2B-----3.77%1.76B--------7.94%1.93B----
Research and development costs 16.11%2.7B-2.21%9.3B-1.27%2.48B-7.28%2.24B-2.71%2.26B2.70%2.32B-6.73%9.51B-0.32%2.51B-18.86%2.42B-6.34%2.32B
Depreciation amortization depletion 4.48%2.36B-5.71%9.05B-2.77%2.28B-6.70%2.26B-6.62%2.26B-6.66%2.26B-4.27%9.6B-3.06%2.34B-5.03%2.42B-5.10%2.42B
-Depreciation and amortization 4.48%2.36B-5.71%9.05B-2.77%2.28B-6.70%2.26B-6.62%2.26B-6.66%2.26B-4.27%9.6B-3.06%2.34B-5.03%2.42B-5.10%2.42B
Operating profit -37.75%1.51B-9.98%8.2B12.34%1.9B-6.67%1.96B-28.05%1.9B-8.88%2.43B6.64%9.1B-27.61%1.69B3.96%2.1B12.71%2.64B
Net non-operating interest income expense -47.57%-425M5.36%-1.17B-7.48%-316M6.35%-280M9.90%-282M11.66%-288M7.65%-1.23B8.98%-294M8.84%-299M5.15%-313M
Non-operating interest expense 47.57%425M-5.36%1.17B7.48%316M-6.35%280M-9.90%282M-11.66%288M-7.65%1.23B-8.98%294M-8.84%299M-5.15%313M
Other net income (expense) -2,113.58%-12.61B987.42%1.41B-81.05%87M11.98%458M164.69%240M195.43%626M-117.77%-159M388.68%459M-12.23%409M19.52%-371M
Gain on sale of security 637.74%285M145.87%289M-19.84%198M181.58%107M113.17%37M91.64%-53M-180.36%-630M--247M--38M-275.63%-281M
Special income (charges) -11,557.76%-13.29B63.99%-260M-69.68%161M-4.39%-214M42.32%-323M123.77%116M30.44%-722M24.36%531M54.85%-205M46.97%-560M
-Less：Restructuring and merger&acquisition 6,258.37%13.29B14.46%1.51B350.32%698M70.81%275M-39.34%330M-54.66%209M-2.15%1.32B-24.76%155M-63.33%161M-46.82%544M
-Less:Other special charges 100.62%2M-187.84%-390M-97.95%3M-238.64%-61M-143.75%-7M-236.55%-325M22.31%444M342.42%146M238.46%44M-63.64%16M
-Gain on sale of business -----17.35%862M3.61%862M--0--0----54.52%1.04B24.92%832M--0--0
Other non- operating income (expenses) -28.77%401M15.84%1.38B14.73%-272M-1.91%565M11.91%526M20.82%563M3.83%1.19B-104.49%-319M26.59%576M8.05%470M
Income before tax -515.74%-11.52B9.43%8.44B-9.95%1.67B-3.26%2.14B-5.06%1.86B64.20%2.77B-4.75%7.71B0.05%1.86B2.41%2.21B26.08%1.96B
Income tax -22.07%392M-70.76%400M46.99%-88M-66.22%203M-141.21%-218M24.50%503M26.20%1.37B67.70%-166M-0.66%601M7.52%529M
Net income -625.28%-11.91B26.71%8.04B-12.99%1.76B20.27%1.93B45.35%2.08B76.70%2.27B-9.54%6.35B-14.63%2.03B3.61%1.61B34.68%1.43B
Net income continuous Operations -625.28%-11.91B26.71%8.04B-12.99%1.76B20.27%1.93B45.35%2.08B76.70%2.27B-9.54%6.35B-14.63%2.03B3.61%1.61B34.68%1.43B
Minority interest income -40.00%3M-16.67%15M0200.00%6M-50.00%4M0.00%5M-10.00%18M3M-66.67%2M33.33%8M
Net income attributable to the parent company -626.57%-11.91B26.84%8.03B-12.86%1.76B20.05%1.93B45.88%2.07B77.00%2.26B-9.54%6.33B-14.76%2.02B3.88%1.61B34.69%1.42B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -626.57%-11.91B26.84%8.03B-12.86%1.76B20.05%1.93B45.88%2.07B77.00%2.26B-9.54%6.33B-14.76%2.02B3.88%1.61B34.69%1.42B
Basic earnings per share -645.37%-5.8930.64%3.88-9.38%0.8725.33%0.9447.76%0.9980.00%1.08-5.71%2.97-12.86%0.967.14%0.7542.55%0.67
Diluted earnings per share -650.47%-5.8930.85%3.86-8.42%0.8724.00%0.9350.00%0.9981.36%1.07-5.45%2.95-11.21%0.958.70%0.7540.43%0.66
Dividend per share 5.26%0.65.48%2.315.26%0.65.56%0.575.56%0.575.56%0.578.96%2.195.56%0.5710.20%0.5410.20%0.54
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Cancer Research
Cancer Research
Intraday+0.03%